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Abstract
Background: Alcoholism is a widespread chronic disorder of complex aetiology with a significant negative impact on the
individual and the society. Mechanisms of ethanol action are not sufficiently well understood at the molecular level and the
pharmacotherapy of alcoholism is still in its infancy. Our study focuses at the cellular and molecular level on ethanol-
induced effects that are mediated through the mu-opioid receptor (MOP) and on the effects of naltrexone, a well-known
antagonist at MOP that is used clinically to prevent relapse in alcoholism.
Methodology/Principal Findings: Advanced fluorescence imaging by Confocal Laser Scanning Microscopy (CLSM) and
Fluorescence Correlation Spectroscopy (FCS) are used to study ethanol effects on MOP and plasma membrane lipid
dynamics in live PC12 cells. We observed that relevant concentrations of ethanol (10–40 mM) alter MOP mobility and
surface density, and affect the dynamics of plasma membrane lipids. Compared to the action of specific ligands at MOP,
ethanol-induced effects show complex kinetics and point to a biphasic underlying mechanism. Pretreatment with naloxone
or naltrexone considerably mitigates the effects of ethanol.
Conclusions/Significance: We suggest that ethanol acts by affecting the sorting of MOP at the plasma membrane of PC12
cells. Naltrexone exerts opposite effects on MOP sorting at the plasma membrane, thereby countering the effects of
ethanol. Our experimental findings give new insight on MOP-mediated ethanol action at the cellular and molecular level.
We suggest a new hypothesis to explain the well established ethanol-induced increase in the activity of the endogenous
opioid system.
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Introduction
The dramatic action of ethanol has puzzled scientists for many
years, and the question whether ethanol evokes its effects in the
brain by acting on lipids or proteins is the subject of a long-
standing debate [1].
Ethanol action on lipids or proteins
Early work focused on ethanol interactions with membrane
lipids. According to the Meyer-Overton theory [2], ethanol, other
organic solvents and anesthetics act by dissolving in the cell
membrane, thus altering its fluidity and other biophysical
parameters such as membrane volume, curvature and lipid phase
transitions [3]. However, concentrations of ethanol that are
relevant in alcohol use (10–40 mM) cause only minute increase in
membrane fluidity, comparable with the effects that would be
caused by temperature increase of less than one tenth of a degree
Celsius [1]. Similar arguments, systematically reviewed in [1],
have been raised against other hypotheses about ethanol acting on
membrane lipids.
The introduction of electrophysiology shifted the focus to
ethanol interactions with membrane proteins, primarily ligand-
gated ion channels. Recent results with the GABA, NMDA and
AMPA receptors suggest that ethanol can bind to a pocket in
certain subunits, altering the sensitivity of the receptor to its ligand
[4]. Again, concentrations of ethanol needed to produce changes
in receptor function have been much higher than those commonly
reached in vivo [1].
The opioid response hypothesis
Interactions between alcohol and the CNS opioid signaling
system are well established and documented in basic research and
clinical practice [5–10] and the usefulness of the opioid-receptor
antagonist naltrexone as an adjunct in the treatment of alcoholism
has placed a spotlight on interactions between ethanol and opioid
signaling. However, in spite of intensive research, mechanisms
involving ethanol interaction with the opioid systems are not yet
fully elucidated. The ‘‘opioid response’’ hypothesis asserts that
ethanol increases the activity of the endogenous opioid system
through the release of opioid peptides, which by interaction with
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hypothesis, supported by the demonstration that opioids stimulate
the release of dopamine [3], has led to the assumption that
medications blocking opioid activity may impede the reinforcing
aspects of ethanol. However, this hypothesis was never proven to
be correct and attempts to measure ethanol-induced increase in
endogenous opioids levels have failed so far.
The lipid-raft hypothesis of ethanol action
At all levels of organization of a living organism, signaling
processes rely on a tight dynamic regulation and synchronization
of signaling molecules and receptors as a critical factor in signal
transduction. Emerging evidence indicates that membrane
compartmentalization into lipid-enriched micro-domains, often
termed lipid rafts plays an important role [14]. The diameter of
lipid rafts varies from a few to several hundred nanometers, and
they are enriched in specific lipids like cholesterol and sphingo-
myelin [15]. Certain proteins are enriched in rafts, others are
embedded in the membrane surrounding the rafts, and some
proteins can shuttle between raft and non-raft membrane
compartments, depending on the functional status of the cell.
Lipid rafts have been suggested to function as platforms
connecting receptor complexes and their signaling pathways [14].
The notion that lipids in model and native membranes are
structurally organized in micro-domains [16] brought about the
idea that ethanol modifies local properties of lipid membranes by
affecting the lipid dynamics [17] and/or structural organization.
Recent results indicating that ethanol alters the lipopolysaccha-
ride-induced redistribution of components of the Toll-like receptor
4 complex within the domain structure of the cell membrane
[18,19], have led Szabo et al. [20] to propose that ethanol
influences the entry or exit of receptor to/from rafts at a lower
concentration than needed for many other effects of ethanol.
Plasma membrane structure, epitomized by lipid rafts, was also
proposed to play a key role in ethanol-induced oxidative stress of
the liver [21].
Our aim is to investigate cellular and molecular mechanisms of
ethanol action at the level of the mu-opioid receptor (MOP) and
the plasma membrane lipids. In addition, we study the molecular
mechanisms of naltrexone action, a MOP antagonist used in
alcoholism treatment. Quantification of molecular numbers and
movement is achieved by FCS/CLSM (Fluorescence Correlation
Spectroscopy/Confocal Laser Scanning Microscopy). This meth-
odology enables us to study subtle changes in MOP/plasma
membrane lipid dynamics in live cells, using ethanol concentra-
tions that are relevant for its behavioral effects, at low, clearly not
intoxicating (10 mM), intermediate (20 mM) and high concentra-
tions (40 mM).
Results
Characterization of the cellular model
Cells derived from the rat pheochromocytoma (PC12) cell line
were stably transformed to express the mu-opioid receptor (MOP)
tagged with the Enhanced Green Fluorescent Protein (EGFP). The
model is described and characterized in details in reference [22],
where it was verified that the cloned construct MOP-EGFP
exhibits properties similar to the native MOP–that the construct
inserted in the plasma membrane, is sensitive and selective to its
specific ligands and coupled to the cellular trafficking machinery
(Fig. 1A).
MOP surface density and lateral mobility at the plasma
membrane were measured using FCS, which is a quantitative
method that relies on the analysis of fluorescence intensity
Figure 1. Effects of ethanol and opioid receptor agonists/
antagonists on the MOP surface density in live PC12 cells. A.
Confocal fluorescence images showing subcellular localization of MOP-
EGFP (green) in PC12 cells under control conditions (left), upon 3 h
treatment with DAMGO (1.0 mM; middle) or naloxone (100 nM; right).
EGFP fluorescence was excited using the 488 nm line of the Ar laser.
Fluorescence emitted in the range 505–540 nm was collected. B.
Schematic drawing of a PC12 cell, showing the location of the
observation volume element during FCS measurements. FCS measure-
ments were always performed on the apical side of the plasma
membrane. C. Typical autocorrelation curve for MOP-EGFP in not
stimulated PC12 cells. FCS measurements were performed and analyzed
as described in the Materials and Methods section. The dots give the
experimental autocorelation curve; the smooth curve is a theoretical
autocorrelation curve derived using a two-component model for free
2D-diffusion (eq. 3). Two fractions of MOP-EGFP were identified that
could be distinguished by differences in lateral mobility,
tD1=(2506150) ms and tD2=(2.561.5) ms. The majority of MOP-EGFP
was characterized by fast mobility, f1=(0.760.2). The amplitude of the
autocorrelation curve is reciprocally proportional to the average
number of MOP-EGFP molecules in the observation volume element
(eq. 3). Autocorrelation curves are the basis for the calculation of
relative changes in receptor surface densities as in the graph below. D.
Relative changes in MOP-EGFP surface density under stimulation with
selected drugs: ethanol (stars), naltrexone (diamonds), naloxone (dots),
morphine (triangles) and DAMGO (squares). Selective ligands at MOP
caused monotonous increase/decrease of MOP-EGFP surface density.
Naloxone and naltrexone, acting as antagonists at MOP monotonously
increased the MOP-EGFP surface density. The agonists DAMGO and
morphine induced rapid internalization of MOP-EGFP, characterized by
an internalization half-time t1/2,agonists=2.5 min. Ethanol induced an
abrupt transient increase in MOP-EGFP surface density, followed by
partial internalization of MOP-EGFP, with an apparent internalization
half-time of t1/2,ethanol=25 min.
doi:10.1371/journal.pone.0004008.g001
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Theoretical background and essential information about the
FCS methodology are given in the Materials and Methods section.
FCS measurements were taken at the apical plasma membrane of
PC12 cells (Fig. 1B). MOP surface density and mobility were
determined by temporal autocorrelation analysis (Fig. 1C). For
detailed explanation, see the Materials and Methods section.
We found that MOP expression levels differ strongly between
cells, with local receptor densities ranging from 1–1000 molecules
in the observation volume element. Assuming homogenous MOP
distribution, the average number of receptors per cell was
estimated to vary between 5610
2–5610
5. Only cells with local
expression levels lower than 100 molecules per observation volume
element were considered for further studies.
Two fractions of MOP were identified at the surface of PC12 cells
that could be distinguished by differences in lateral mobility. The
majority of MOP showed fast lateral mobility, tMOP,1=
(2506150) ms. The slowly moving fraction, tMOP,2=(2.561.5) ms,
dissipated upon cholesterol depletion and was enriched in detergent
insoluble cellular extracts suggesting that this fraction corresponds to
MOP associated with lipids and other components in detergent
insoluble protein/lipid-rich micro-domains [22].
Ethanol effects on MOP
In PC12 cells incubated with 20 or 40 mM ethanol, a transient
increase in MOP surface density followed by partial MOP
internalization was observed (Fig. 1D). Ethanol also increased
the lateral mobility of MOP in the plasma membrane, as reflected
by the shift of the autocorrelation curve towards shorter
correlation times (Fig. 2, stars). In comparison to the effects of
ethanol, specific ligands at MOP caused monotonous changes in
receptor surface density. DAMGO and morphine caused a
decrease in MOP surface density at similar rates, kint=(0.460.1)
min
21, but to a different extent (Fig. 1D). Like ethanol, these
agonists increased the lateral mobility of MOP (data not shown).
The antagonists at MOP naloxone and naltrexone increased
monotonously the surface density of MOP (Fig. 1D) and
significantly reduced its lateral mobility (Fig. 2, open circles).
Ethanol effects on plasma membrane lipids
The structural organization/dynamics of plasma membrane
lipids was studied using the general fluorescent lipid marker
DiIC18(5) (Fig. 3A). In untreated PC12 cells, the marker yielded
complex fluorescence intensity bursts, consisting of alternating
high/low-intensity spurts separated by prolonged intervals (about
0.7 s) of low-intensity fluorescence fluctuations (Fig. 3B). The
intricate fluorescence pattern reflects complex dynamics/structural
organization of plasma membrane lipids. Consequently, the
corresponding autocorrelation curves were ‘‘stretched’’ and the
characteristic decay times spanned over several orders of
magnitude (Figs 4B and 5A).
After exposure to ethanol, marked changes in the lipid dynamics
were observed (Figs 3C, 4B and 5A). As can be seen in Fig. 3, the
large fluorescence intensity bursts (Fig. 3B) gradually disappeared
and the fluctuation pattern changed its complex form to regular
fluorescence intensity fluctuations (Fig. 3C). Correspondingly, the
autocorrelation curve ‘‘shifted to the left’’, showing shorter
characteristic correlation times (Figs 4B and 5A).
Ethanol effects on plasma membrane lipids are mediated
through MOP
The effect of 20 mM ethanol on the mobility of MOP and the
plasma membrane lipid dynamics were comparable to the effect of
10 mM methyl-b-cyclodextrin (MbCD), a compound known to
extract cholesterol from the plasma membrane (Fig. 4). However,
the underlying mechanisms seem to be different. As expected, the
effects caused by MbCD did not depend on the presence of MOP
Figure 2. Normalized temporal autocorrelation curves showing
the effect of ethanol and naltrexone on MOP-EGFP lateral
mobility in the plasma membrane. The shift of the autocorrelation
curve to shorter correlation times (stars) indicates that ethanol
somewhat impels the lateral mobility of MOP-EGFP. In contrast,
naltrexone markedly slowed down the lateral mobility of MOP-EGFP.
The temporal autocorrelation curve (open circles) assumed a complex
shape, indicating the formation of a slowly moving component.
doi:10.1371/journal.pone.0004008.g002
Figure 3. Dynamics of plasma membrane lipids under MOP
stimulation with naltrexone and ethanol. A. Structural formula of
the general lipid marker 1,19-dioctadecyl-3,3,39,39-tetramethylindocar-
bocyanine perchlorate (DiIC18(5)) used as indicator of the plasma
membrane lipid dynamics. DiIC18(5) was excited using the HeNe
633 nm laser. Fluorescence emitted in the range above 650 nm was
collected. B. Fluorescence intensity fluctuations recorded in control
cells. The corresponding temporal autocorrelation curve is shown in
Fig 5A (black curve). C. Fluorescence intensity fluctuations showing the
effect of 40 mM ethanol on the dynamics of plasma membrane lipids
recorded after 15 min exposure to ethanol.
doi:10.1371/journal.pone.0004008.g003
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membrane lipids appeared to be enforced through MOP. In
control cells, regular PC12 cells that express very low if any MOP,
the direct effect of ethanol on the lipid dynamics was very slow and
moderate changes could be observed only after prolonged, several
hours’ exposure (data not shown). This is in contrast with the
modified, MOP expressing PC12 cells, where effects of ethanol on
the plasma membrane lipid dynamics were readily observable
shortly after exposure to ethanol. In addition, ethanol effects on
the lipid dynamics could be modulated by specific ligands at MOP,
as discussed in the following section.
Naloxone and naltrexone modulate the effect of ethanol
on MOP and plasma membrane lipid dynamics
The effects of naloxone or naltrexone on MOP-ethanol
interactions were investigated in two paradigms. To study the
preventive potential of naloxone/naltrexone, cells were pre-
incubated with 100 nM naltrexone or 200 nM naloxone for 10–
30 min and thereafter exposed to ethanol (10, 20 or 40 mM). Pre-
exposure to the antagonists at MOP slowed-down the effects of
ethanol (Fig. 5A).
The potential of naloxone/naltrexone to reverse the ethanol-
induced effects was studied by exposing the cells to 20 mM ethanol
for 30 min, followed by a treatment with naloxone/naltrexone.
Effects caused by pre-incubation with ethanol could not be readily
reversed by naloxone or naltrexone (Fig. 5B).
Discussion
Due to its simple chemical structure, alcohol is often classified as
a drug with a nonspecific primary site of action. The notion that
ethanol interferes predominantly with membrane-associated
processes has brought in focus plasma membrane lipids [1,18–
21] and plasma membrane proteins [1,4,23]. In early studies, these
components were strictly delineated [1], although it has been
suggested that ethanol acts both on proteins and their immediate
surroundings, the so-called annular lipids, exerting its effects by
disrupting the protein-lipid interactions [24–26]. Until recently
such interactions were not easily accessible for study in live cells
due to the lack of adequate experimental methodology. Current
advances in molecular fluorescence imaging, in particular the
FCS/CLSM methodology, now open the opportunity to study
nondestructively molecular interactions in a restricted area of the
plasma membrane (observation volume element about 400 nm in
diameter), in real time and with single-molecule sensitivity [22].
We observed profound effects of ethanol on the MOP receptor
surface density and mobility, as well as on the dynamics/
organization of lipid constituents in the plasma membrane. Our
findings, summarized in Table 1, show that effects of ethanol are
markedly different from the effect of opioid-specific agonists and
antagonists. Agonists at MOP cause fast receptor internalization
with internalization half-times 2–5 min (Fig. 1D). Similarly to the
effect of agonists, ethanol promotes MOP lateral mobility at the
plasma membrane. Ethanol also induces MOP internalization;
however the time course of ethanol-induced MOP internalization
is complex and markedly different from the course of ligand-
induced internalization (Fig. 1D). In contrast, antagonists at MOP
appear to stall the receptor at the plasma membrane, cause
monotonous increase in MOP surface density (Fig. 1D) and slow-
down its lateral mobility (Fig. 2, open circles).
The transient increase in MOP surface density of (Fig. 1D) is
especially interesting. FCS analysis reveals that relevant concen-
trations of ethanol induce a 3-fold increase in MOP surface density
in 10 min. It was shown previously that MOP expression is not
increased in PC12 cells exposed to ethanol [22,27], suggesting that
elevated MOP surface density is due to differences in trafficking
and/or sorting of the existing pool of MOP. One possibility may
be that MOP is replenished from the intracellular pool by faster
recruitment of transporting vesicles to the plasma membrane. This
Figure 4. Effects of ethanol on the dynamics of MOP and
plasma membrane lipids compared to the effects of cholester-
ol depletion by MbCD. Normalized autocorrelation curves showing
changes in the dynamics of A. MOP and B. plasma membrane lipids,
caused by 20 mM ethanol (dark gray) or 10 mM MbCD (light gray) as
compared to the dynamics in control cells (black curve).
doi:10.1371/journal.pone.0004008.g004
Figure 5. Modulation of ethanol-induced effects by naloxone.
A. Normalized autocorrelation curves reflecting the dynamics of plasma
membrane lipids in control cells (black curve), cells treated with 20 mM
ethanol for 30 min (dark gray) and cells treated with 20 mM ethanol for
30 min, followed by treatment with 200 nM naloxone for 60 min (light
gray). The characteristic decay time of the autocorrelation curves is
decreased even after addition of naloxone. B. Normalized autocorre-
lation curves reflecting the dynamics of plasma membrane lipids in cells
exposed to 200 nM naloxone for 30 min (black curve), cells treated with
200 nM naloxone for 30 min, followed by a 60 min exposure to 20 mM
ethanol (dark gray) and cells treated with 200 nM naloxone for 30 min,
followed by a 120 min exposure to 20 mM ethanol. The characteristic
decay time of the autocorrelation curves remained unchanged,
suggesting that the dynamics of MOP and plasma membrane lipids is
largely unaffected. These findings suggest that effects of ethanol on the
dynamics of MOP and the plasma membrane lipids are not easily
reversed by naloxone or naltrexone. However, pre-treatment with these
substances slows down the effects of ethanol.
doi:10.1371/journal.pone.0004008.g005
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the plasma membrane and restoring the properties that were
affected by ethanol action. However, our preliminary studies on
other types of opioid receptors suggest that this is not the main
pathway. More likely, the apparent increase in MOP surface
density reflects the redistribution of MOP at the plasma
membrane. Oligomerization of opioid and other G-protein
Coupled Receptors (GPCRs) [28–30] along with sorting in plasma
membrane micro-domains [31] are known to take place at the
plasma membrane. Dissociation of oligomers and/or release of
multiple MOP molecules from micro-domains would be reflected
in temporal autocorrelation analysis as an apparent increase in
MOP surface density accompanied by enhanced lateral mobility,
as we observed in our study. However, to prove unequivocally
these mechanisms additional studies using brightness analysis [32]
and Fluorescence Cross-Correlation Spectroscopy (FCCS) [22] are
required.
Ethanol is known to affect cholesterol trafficking in CNS cells
in vitro [33] and may exhibit cholesterol-reducing effects.
Molecular dynamics simulations indicate that ethanol readily
assembles in lipid bilayers (within 10 ns), enlarging the area per
lipid and yielding a ‘‘softer’’ bilayer with enhanced lipid diffusion
[34]. The effects of ethanol on plasma membrane lipid dynamics
are comparable to the effect of the cholesterol depleting agent
MbCD (Fig. 4). However, the effects of ethanol on the plasma
membrane lipid dynamics appeared to be mediated through
MOP and could be modulated by antagonists at MOP (Table 2).
This finding is difficult to explain by the general mechanisms
mentioned above.
Based on the presented results, the following biphasic
mechanism of ethanol action can be envisaged for MOP-mediated
effects in PC12 cells. Ethanol dissipates the plasma membrane
micro-domains, thereby releasing the ‘‘associated’’ form and
rendering ‘‘free’’ MOP. This is reflected in FCS measurements
as increase in MOP surface density, enhanced MOP mobility and
intensified plasma membrane lipid dynamics. Increased surface
density of ‘‘free’’ MOP potentiates the endogenous opioid
signaling and activates the cellular internalization machinery,
secondarily causing the sharp reduction in MOP surface density.
Antagonists at MOP seem to work in the opposite direction–
naltrexone and naloxone promote MOP association into larger
molecular complexes, thereby countering and slowing down the
action of ethanol.
A new hypothesis on MOP-ethanol interaction
It is widely assumed that ethanol increases the activity of the
endogenous opioid system through the release of opioid peptides
and that anticraving/antihedonic effects of naltrexone (ReviaH),
used clinically to prevent relapse in alcoholism are achieved
through antagonizing the effect of opioid peptides released by
ethanol that are acting at the MOP receptor. However, attempts
to measure ethanol-induced increase in endogenous opioids
levels have failed so far. In addition, animal model studies
showed that MOP knockout mice do not self-administer alcohol
[35] and that neither null-mutation of preproenkephalin, nor
homozygous knockout of proopiomelanocortin (the precursor of
b-endorphin) affects the voluntary intake of ethanol in mice [36–
38]. Thus, modification of b-endorphin or enkephalin levels,
which are the endogenous peptide ligands at MOP does not
affect the preference of ethanol intake in mice whereas the
elimination of MOP does.
Our findings enable us to speculate on an alternative
molecular mechanism for the well established ethanol-induced
opioid surfeit. We suggest that ethanol affects MOP-mediated
signaling by changing the distribution of MOP at the plasma
membrane. It is possible that transient increase in ‘‘free’’ MOP,
rather than the release of endogenous endorphins increases the
activity of the endogenous opioid system. The subsequent
reduction in MOP surface density (Fig. 1D) might explain the
unpleasant feelings in the aftermath of exposure to ethanol and the
finding that MOP density is reduced in certain brain areas after
chronic ethanol intake [39]. In line with this reasoning, antagonists
at MOP might counteract the effect of ethanol by sorting MOP to
the ‘‘aggregated’’ state, thereby slowing down MOP redistribution,
rather than by antagonizing the effect of endogenous opioid
ligands.
It is important to underline that our results apply for the cellular
model studied and the link between physiological actions of
ethanol and the clinical effects of opioid antagonists needs still to
be established.
Table 1. A summary of ethanol effects at MOP and plasma membrane lipid dynamics compared to the effects of specific ligands.
Compound MOP Lipid dynamics Probable cellular processes
surface density mobility
DAMGO Monotonous decrease Increased Fast MOP internalization
Morphine t1/2<2–5 min
Naltrexone Monotonous increase Decreased Complex MOP sorting*
Naloxone t1/2<20 min
Ethanol Transient increase followed by
reduction
Increased Fast MOP sorting**/internalization
*Naltrexone and naloxone promote MOP association into larger molecular complexes.
**Ethanol dissipates the plasma membrane micro-domains, thereby releasing the ‘‘associated’’ form and rendering ‘‘free’’ MOP.
doi:10.1371/journal.pone.0004008.t001
Table 2. Naloxone and naltrexone modulate the effect of
ethanol on the plasma membrane lipid dynamics.
Pre-treatment (time) Ethanol/mM
Full effect of ethanol
visible after
Naloxone/nM Naltrexone/nM
- - 20 30 min
100 (10 min) 40 50 min
200 (30 min) 20 .120 min
doi:10.1371/journal.pone.0004008.t002
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An important aspect of our study is the possibility to monitor
local changes in protein and lipid dynamics and observe how it is
affected by a non-specific substance like ethanol. The possibility to
probe the lipid micro-environment around plasma membrane
bound receptors [22,40] may open a way to study important
aspects of the role of lipids in cell surface receptor activation, an
issue that is particularly relevant for the mechanism of action of
pharmacological substances like general anesthetics that have the
potential to perturb the lipid matrix and in this way may induce
receptor mediated signaling cascades [41].
The experimental results presented in this study give new insight
into the cellular and molecular mechanism of MOP-mediated
ethanol action in the PC12 cellular model. Ethanol affects MOP
mobility and the plasma membrane lipid dynamics, hinting at
MOP release from micro-domains and redistribution at the
plasma membrane. Naloxone and naltrexone apparently promote
MOP association into larger molecular complexes and markedly
slow down the effects of ethanol.
Materials and Methods
Confocal Laser Scanning Microscopy and Fluorescence
Correlation Spectroscopy (CLSM/FCS)
Quantitative imaging was achieved by integrating Fluorescence
Correlation Spectroscopy with Confocal Laser Scanning Micros-
copy (FCS/CLSM). Amalgamation of these methods yielded a
hybrid instrument for quantitative imaging with the capacity to
investigate dynamic processes in live cells in real time with single-
molecule sensitivity.
Instrumental setup
FCS/CLSM measurements were performed on a uniquely
modified ConfoCor3 instrument (Carl Zeiss, Jena, Germany)
consisting of an inverted microscope for transmitted light and
epifluorescence (Axiovert 200 M); a VIS-laser module comprising
the Ar/ArKr (458, 477, 488 and 514 nm), HeNe 543 nm and
HeNe 633 nm lasers; scanning module LSM 510 META modified
to enable detection using silicon avalanche photodiodes (SPCM-
AQR-1X; PerkinElmer, USA) and an FCS module with three
detection channels. Images were recorded at a 5126512 pixel
resolution. The C-Apochromat 406/1.2 W UV-VIS-IR objective
was used throughout.
For imaging of live cells, a cell cultivation system consisting of a
heated microscope stage (Heating insert P), incubator box
(Incubator S), atmosphere-controlling device (CTI-Controller
3700) equipped with a humidifier and a temperature controlling
device (Tempcontrol 37-2 digital) was applied. The CTI-
Controller 3700 supplies the cultivation chamber with a heated
mixture of CO2/air. The CO2 concentration and the temperature
were continuously monitored and regulated by a digital feedback
control algorithm, enabling a regulated dispersion of CO2 into the
air stream and steady heating.
Theoretical background on FCS
FCS is a physical method that relies on the measurement and
analysis of fluorescence intensity fluctuations to characterize
quantitatively the investigated system and extract information
about the dynamics of processes leading to fluorescence intensity
fluctuations [42–47]. To measure fluorescence intensity fluctua-
tions in a diffraction limited volume element, the optical setup of a
confocal microscope is used (a schematic presentation is given in
Fig. 6). In the microscope, incident laser light is reflected by a
dichroic mirror and sharply focused by the objective to form a
diffraction limited volume element. A confocal aperture is set in
the image plane to reject the out-of-focus light and enhance
further the signal-to-noise ratio. The pinhole also reduces the
volume from which fluorescence is detected, providing an elliptical
detection volume element (magnified in the insert) with sub-
micrometer resolution in two lateral directions–the diffraction
limited detection volume element is typically smaller than
0.5 mm60.5 mm62 mm. Light emitted by fluorescing molecules
passing through the observation volume element or undergoing
transformations that lead to fluorescence emmision/loss is
separated from the exciting radiation and the scattered light by
the dichroic mirror and a barrier filter, transmitted to the detector,
recorded in real time (Fig. 6A, B) and analyzed using statistical
methods for fluctuation analysis. Most often, fluorescence intensity
fluctuations are analyzed using temporal autocorrelation analysis
(Fig. 6C, D), as done in this study, but other approaches can also
be applied [45].
In temporal autocorrelation analysis the normalized autocorre-
lation function G(t) is first derived. G(t) gives the correlation
between the deviation of fluorescence intensity, measured at a
certain time t, hI(t)=I(t)2ÆI(t)æ, and its intensity measured at a later
time t+t, hI(t+t)=I(t+t)2ÆI(t)æ, from the average fluorescence
intensity ÆI(t)æ:
G t ðÞ ~1z
SLIt ðÞLIt zt ðÞ T
SIt ðÞ T
2 ð1Þ
The normalized autocorrelation function G(t) is then plotted for
different autocorrelation times t, yielding the experimental autocor-
relation curve (Fig. 6C, D). In molecular systems undergoing
stochastic fluctuations, one would observe random variations of G(t)
around the value G(t)=1. For processes that are not random, one
typically observes a maximal limiting value of G(t)a stR0,
decreasing to the value of G(t) = 1a tl o n gt i m e s ,i n d i c a t i n gt h a t
correlation between the initial and the current property value has
been lost (Fig. 6C, D). In a simple system with one component and a
single characteristic fluctuation frequency, the autocorrelation curve
has a simple sigmoid form (Fig. 6C). The amplitude of the
autocorrelation function G(t)a stR0, is inversely proportional to
the absolute concentration of the fluorescing molecules, whereas the
range of t-values over which G(t) changes rapidly as a function of t
gives the time scale at which the fluorescence intensity fluctuations
occur. In a system with multiple components, for example two
components that differ in their diffusion properties, the autocorre-
lation function assumes a more complex shape (Fig. 6D). The
amplitude of the autocorrelation function as tR0 is inversely
proportional to the average number of all fluorescent particles in the
observation volume element, multiple inflection points indicate that
fluctuations in the signal occur at two time scales (tD1 and tD2)a n d
the relative amounts of the two components can be estimated from
the amplitudes 12f and f.
In real experiments, the autocorrelation curves are fitted
numerically using theoretical autocorrelation functions. To derive
an appropriate autocorrelation function it is very important to take
notice of all processes that may lead to fluctuations in the
fluorescence signal, like diffusion, active transport, chemical
reactions, structural transformation, photophysical processes etc.
because all processes leading to statistical fluctuations in the
fluorescence signal will induce a characteristic decay time in the
autocorrelation curve [45–47]. For example, if the passage of
fluorescent particles is governed solely by diffusion, the exper-
imental autocorrelation curve (Fig. 6C) can be fitted by an
autocorrelation function describing free three-dimensional diffu-
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In equation (2a), N is the average number of fluorescent molecules
in the observation volume element; wxy and wz give the 1/e
2 radius
of the observation volume element in the radial and axial
direction, respectively; tD is the average time a fluorescent particle
stays in the observation volume element. In FCS terminology, tD is
called the lateral diffusion time and is directly related to the size of
the observation volume element and the diffusion coefficient (D) of
the fluorescent particles:
tD~
w2
xy
4:D
ð2bÞ
If the example given in Fig. 6D represents ligand binding to
plasma membrane associated receptors, the corresponding theo-
retical autocorrelation function would be:
G(t)~1z
1
N
: 1{f
1z t
tD1
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In equation (2c) N is the average number of ligand molecules in the
observation volume element; the first term in the parenthesis
describes free three-dimensional diffusion of unbound ligand
molecules; the second term describes two-dimensional diffusion of
the membrane-associated ligand-receptor complexes; tD1 and tD2
are the lateral diffusion times for the unbound and bound ligand,
respectively. The relative amount of unbound versus bound ligand
molecules is given by the ratio of (12f ) over f.
Figure 6. Schematic presentation of the instrumentation for FCS/CLSM. To induce fluorescence, the sample is illuminated by incident laser
light. The irradiating laser beam is reflected by a dichroic mirror and sharply focused by the objective to form a diffraction limited volume element. A
confocal aperture, set in the image plane to reject the out-of-focus light, further reduces the volume from which fluorescence is detected. This is
crucial for providing an elliptical observation volume element and enabling submicrometer resolution and quantitative analysis. Following the
absorption of energy, fluorescent molecules lose energy through photon emission. Light emitted by fluorescing molecules passing through the
confocal volume element (magnified in the insert) is separated from the exciting radiation and the scattered light by a dichroic mirror and barrier
filter, and transmitted to the detector. The number of pulses originating from the detected photons, recorded during a specific time interval,
corresponds to the measured light intensity. Examples of fluorescence intensity fluctuations recorded in systems with one component undergoing A.
free three-dimensional diffusion or B. free three-dimensional diffusion with binding to a surface. Corresponding autocorrelation curves are shown in
C and D, respectively. C. Autocorrelation curve G(t) fitted using equation (2a). The average number of molecules in the observation volume element
is determined from the amplitude of the autocorrelation function (1/N=0.94), and average residence time tD from the inflection point. D.
Autocorrelation curve G(t) fitted using equation (2c). The complex shape of the autocorrelation curve indicates that two components with different
diffusion times, tD1 and tD2, are present. The average number of particles in the observation volume element is determined from the amplitude of the
autocorrelation curve (1/N=0.8). The ratio of the free fraction versus the bound is given by the ratio of the relative amplitudes (12f )/f.
doi:10.1371/journal.pone.0004008.g006
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Fluorescence intensity fluctuations were recorded in arrays of
10–30 consecutive measurements, each measurement lasting 5–
10 s. Averaged curves were analyzed using the FCS/CLSM
running software for online data analysis, or exported and fitted
offline using the IGOR Pro 5 data analysis software (WaveMetrics,
Inc. Portland, USA). In either case, the nonlinear least-square
fitting of the autocorrelation curve was performed using the
Levenberg-Marquardt algorithm.
The experimental autocorrelation curves were fitted using
models for free two-dimensional diffusion:
G(t)~1z
1
N
:
X 3
i~1
fi
1z t
tDi
  
0
@
1
A: ð3Þ
Quality of the fitting was evaluated by visual inspection and by
residuals analysis. The model with the smallest number of
variables for which good fitting was achieved was selected as
representative.
Cell culture
PC12 cells were obtained from ATCC through LGC Promo-
chem (Bora ˚s, Sweden). For cloning and multiplication purposes,
the cells were cultured in collagen-coated flasks in RPMI 1640
medium supplemented with 5% fetal bovine serum, 10% heat-
inactivated horse serum, 100 U/mL penicillin and 100 mg/mL
streptomycin (all from Invitrogen, Sweden). The cells were
maintained at 37uC in a humidified 5% CO2 incubator. The
medium was replaced every 2–3 days. For CLSM and FCS
experiments, the cells were plated on 8-well chambered coverslips
(Nalge Nunc International, USA) and grown in phenol-red free
RPMI medium supplemented with 10% horse serum, 5% fetal
bovine serum, penicillin (100 units/mL) and streptomycin
(100 mg/mL) in humidified 5% CO2 atmosphere at 37uC.
Average cell density at plating was about 1610
5 cells/cm
2,i n
300 mL medium. The cells were subjected to CLSM/FCS analysis
2 to 3 days after plating in the chambered coverslips.
Fluorescent staining of plasma membrane lipids
Lipophilic 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocya-
nine perchlorate dye (DiIC18(5); Vybrant Cell-Labeling Solution
V-22887, Molecular Probes/Invitrogen Labeling & Detection,
Eugene, USA) was used as a general membrane stain [48,49].
Cells were incubated with the labeling solution diluted with the
culture medium (1:200) for 7–10 min at 37uC. Shorter incubation
times (2 min and 5 min) were also tested, but did not yield uniform
staining of the cellular plasma membrane. Excess of the dye was
removed by washing three times with the cell culture medium.
Cholesterol depletion
A stock solution of 100 mM methyl-b-cyclodextrin (MbCD;
Sigma-Aldrich, St. Louis, USA) was prepared in phosphate-
buffered saline and stored at 4uC. Prior to the measurements, the
stock solution was diluted with the culture medium to yield a
10 mM solution. We incubated the cells with 10 mM MbCD for
30 min at 37uC, a procedure that was shown not to be toxic for
PC12 cells [50]; washed three times with the culture medium and
stained with DiIC18(5) as described above. We did not observe any
effect of the applied treatment on cellular viability during the
observation time (several hours).
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